Open AccessDiagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the S tudy G roup of L iver and M etabolism, C hinese S ociety of E ndocrinology (非酒精性脂肪性肝病与相关代谢紊乱诊疗共识——中华医学会内分泌学分会肝病与代谢学组)
Author(s) -
Gao Xin,
Fan JianGao
Publication year - 2013
Publication title -
journal of diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.949
H-Index - 43
eISSN - 1753-0407
pISSN - 1753-0393
DOI - 10.1111/1753-0407.12056
Subject(s) - medicine , fatty liver , metabolic syndrome , disease , population , diabetes mellitus , obesity , liver disease , environmental health , endocrinology
Non‐alcoholic fatty liver disease ( NAFLD ) is the most common liver disease in W estern countries, affecting 20%–33% of the general population. Large population‐based surveys in C hina indicate a prevalence of approximately 15%–30%. Worldwide, including in C hina, the prevalence of NAFLD has increased rapidly in parallel with regional trends of obesity, type2 diabetes and metabolic syndrome. In addition, NAFLD has contributed significantly to increased overall, as well as cardiovascular and liver‐related, mortality in the general population. In view of rapid advances in research into NAFLD in recent years, this consensus statement provides a brief update on the progress in the field and suggests preferred approaches for the comprehensive management of NAFLD and its related metabolic diseases.